REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 87 filers reported holding REATA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $371,000 | -31.4% | 6,613 | 0.0% | 0.04% | -27.1% |
| Q3 2018 | $541,000 | +67.5% | 6,613 | -28.5% | 0.06% | +59.5% |
| Q2 2018 | $323,000 | +70.0% | 9,244 | 0.0% | 0.04% | +60.9% |
| Q1 2018 | $190,000 | -27.5% | 9,244 | 0.0% | 0.02% | -28.1% |
| Q4 2017 | $262,000 | -8.7% | 9,244 | 0.0% | 0.03% | -17.9% |
| Q3 2017 | $287,000 | -1.7% | 9,244 | 0.0% | 0.04% | -9.3% |
| Q2 2017 | $292,000 | +39.7% | 9,244 | 0.0% | 0.04% | +30.3% |
| Q1 2017 | $209,000 | +3.5% | 9,244 | 0.0% | 0.03% | -2.9% |
| Q4 2016 | $202,000 | +61.6% | 9,244 | +94.8% | 0.03% | +54.5% |
| Q3 2016 | $125,000 | +33.0% | 4,746 | 0.0% | 0.02% | +22.2% |
| Q2 2016 | $94,000 | – | 4,746 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |